169 related articles for article (PubMed ID: 32690632)
41. [Phenol-insoluble vaccine against human brucellosis: evaluation of the immunogenic power in guinea pigs].
Bolpe J; de Lapenta DF; García-Carrillo C
Rev Inst Med Trop Sao Paulo; 1991; 33(1):23-7. PubMed ID: 1843392
[TBL] [Abstract][Full Text] [Related]
42. Induction of specific cell-mediated immune responses and protection in BALB/c mice by vaccination with outer membrane vesicles from a Brucella melitensis human isolate.
Bagheri Nejad R; Yahyaraeyat R; Es-Haghi A; Nayeri Fasaei B; Zahraei Salehi T
APMIS; 2019 Dec; 127(12):797-804. PubMed ID: 31514254
[TBL] [Abstract][Full Text] [Related]
43.
Verdiguel-Fernández L; Oropeza-Navarro R; Ortiz A; Robles-Pesina MG; Ramírez-Lezama J; Castañeda-Ramírez A; Verdugo-Rodríguez A
J Microbiol Biotechnol; 2020 Apr; 30(4):497-504. PubMed ID: 31986561
[TBL] [Abstract][Full Text] [Related]
44. Immunization against Brucella infection. 8. The response of Cynomolgus philippinensis, guinea-pigs and pregnant goats to injection by the Rev I strain of Brucella melitensis.
ELBERG SS; FAUNCE WK
Bull World Health Organ; 1962; 26(3):421-36. PubMed ID: 13889789
[TBL] [Abstract][Full Text] [Related]
45. The Brucella melitensis M5-90ΔmanB live vaccine candidate is safer than M5-90 and confers protection against wild-type challenge in BALB/c mice.
Zhang J; Yin S; Yi D; Zhang H; Li Z; Guo F; Chen C; Fang W; Wang J
Microb Pathog; 2017 Nov; 112():148-155. PubMed ID: 28916316
[TBL] [Abstract][Full Text] [Related]
46. The candidate vaccine strain Brucella ovis ∆abcBA is protective against Brucella melitensis infection in mice.
Costa LF; Cabello AL; Batista DFA; Chaki SP; de Figueiredo P; da Paixão TA; Rice-Ficht AC; Ficht TA; Santos RL
Microbiol Immunol; 2020 Nov; 64(11):730-736. PubMed ID: 32965738
[TBL] [Abstract][Full Text] [Related]
47. Protection of mice against brucellosis by vaccination with Brucella melitensis WR201(16MDeltapurEK).
Hoover DL; Crawford RM; Van De Verg LL; Izadjoo MJ; Bhattacharjee AK; Paranavitana CM; Warren RL; Nikolich MP; Hadfield TL
Infect Immun; 1999 Nov; 67(11):5877-84. PubMed ID: 10531243
[TBL] [Abstract][Full Text] [Related]
48. Vaccination with a Brucella ghost developed through a double inactivation strategy provides protection in Guinea pigs and cattle.
He C; Yang J; Zhao H; Liu M; Wu D; Liu B; He S; Chen Z
Microb Pathog; 2022 Jan; 162():105363. PubMed ID: 34919994
[TBL] [Abstract][Full Text] [Related]
49. [Immunogenic properties of brucella protective antigen upon revaccination].
Dranovskaia EA; Vershilova PA
Zh Mikrobiol Epidemiol Immunobiol; 1976; (12):94-9. PubMed ID: 828826
[TBL] [Abstract][Full Text] [Related]
50. [ATTEMPT AT VACCINATION OF GUINEA PIGS AGAINST BRUCELLA MELITENSIS BY MEANS OF A KILLED VACCINE].
QUATREFAGES H; CARRERE L; PETITDIDIER M
Ann Inst Pasteur (Paris); 1965 Aug; 109():305-9. PubMed ID: 14336050
[No Abstract] [Full Text] [Related]
51. Venezuelan field trials of vaccines against brucellosis in swine.
Lord VR; Cherwonogrodzky JW; Schurig GG; Lord RD; Marcano MJ; Meléndez GE
Am J Vet Res; 1998 May; 59(5):546-51. PubMed ID: 9582954
[TBL] [Abstract][Full Text] [Related]
52. A pregnant mouse model for the vertical transmission of Brucella melitensis.
Wang Z; Wang SS; Wang GL; Wu TL; Lv YL; Wu QM
Vet J; 2014 Apr; 200(1):116-21. PubMed ID: 24462801
[TBL] [Abstract][Full Text] [Related]
53. The effects of the conjunctival Brucella vaccine on some biochemical parameters in sheep.
Çiftci G; Yiğit Ö; Çiftci A
Trop Anim Health Prod; 2019 Feb; 51(2):355-361. PubMed ID: 30145690
[TBL] [Abstract][Full Text] [Related]
54. Evaluation of the immunogenicity and the protective efficacy in mice of a DNA vaccine encoding SP41 from Brucella melitensis.
Al-Mariri A; Abbady AQ
J Infect Dev Ctries; 2013 Apr; 7(4):329-37. PubMed ID: 23592643
[TBL] [Abstract][Full Text] [Related]
55. Immuno-pathophysiological responses of mouse model to experimental infection with Brucella melitensis and its lipopolysaccharides via intraperitoneal route.
Osman AY; Abdullah FFJ; Kadir AA; Saharee AA
Microb Pathog; 2016 Nov; 100():17-29. PubMed ID: 27591112
[TBL] [Abstract][Full Text] [Related]
56. B. melitensis rough strain B115 is protective against heterologous Brucella spp. infections.
Adone R; Francia M; Pistoia C; Pesciaroli M; Pasquali P
Vaccine; 2011 Mar; 29(14):2523-9. PubMed ID: 21300102
[TBL] [Abstract][Full Text] [Related]
57. [Immune response and reproductive consequences in experimentally infected ewes with Brucella ovis during late pregnancy].
Paolicchi FA; Nuñez M; Fiorentino MA; Malena RC; Trangoni M; Cravero S; Estein SM
Rev Argent Microbiol; 2013; 45(1):13-20. PubMed ID: 23560783
[TBL] [Abstract][Full Text] [Related]
58. Protection against brucellosis in goats, five years after vaccination with reduced-dose Brucella melitensis Rev 1 vaccine.
Díaz-Aparicio E; Hernández L; Suárez-Güemes F
Trop Anim Health Prod; 2004 Feb; 36(2):117-21. PubMed ID: 14998310
[TBL] [Abstract][Full Text] [Related]
59. Evaluation of Brucella melitensis B115 as rough-phenotype vaccine against B. melitensis and B. ovis infections.
Adone R; Francia M; Ciuchini F
Vaccine; 2008 Sep; 26(38):4913-7. PubMed ID: 18675869
[TBL] [Abstract][Full Text] [Related]
60. Immunopathological responses and kinetics of Brucella melitensis Rev 1 infection after subcutaneous or conjunctival vaccination in rams.
Muñoz PM; de Miguel MJ; Grilló MJ; Marín CM; Barberán M; Blasco JM
Vaccine; 2008 May; 26(21):2562-9. PubMed ID: 18423950
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
